913835-30-0 Usage
Uses
Used in Organic Synthesis:
2-CHLORO-5-ETHOXYBENZENEBORONIC ACID 97 is used as a building block in organic synthesis for the creation of a diverse range of organic compounds. Its unique structure allows for versatile reactions, making it a valuable component in the synthesis of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-CHLORO-5-ETHOXYBENZENEBORONIC ACID 97 is employed as a key intermediate in the development of new drugs. Its ability to form stable bonds with other molecules makes it an essential component in the synthesis of potential therapeutic agents.
Used in Laboratory Applications:
2-CHLORO-5-ETHOXYBENZENEBORONIC ACID 97 is utilized in laboratory settings for research purposes. Its high purity and reactivity make it suitable for conducting experiments and exploring new chemical reactions.
Used in Industrial Applications:
This boronic acid derivative is also used in industrial applications, where its unique properties are leveraged to produce specialty chemicals and materials. Its versatility and reactivity contribute to the development of innovative products in various sectors.
Check Digit Verification of cas no
The CAS Registry Mumber 913835-30-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,3,8,3 and 5 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 913835-30:
(8*9)+(7*1)+(6*3)+(5*8)+(4*3)+(3*5)+(2*3)+(1*0)=170
170 % 10 = 0
So 913835-30-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H10BClO3/c1-2-13-6-3-4-8(10)7(5-6)9(11)12/h3-5,11-12H,2H2,1H3
913835-30-0Relevant articles and documents
5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS
-
Page/Page column 28, (2009/12/28)
The present invention relates to derivatives of 5,6-bisaryl-2-pyridine-carboxamide, their preparation and their application in therapeutics as antagonists of urotensin II receptors.
